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Abstract
Human mesenchymal stem cells (hMSCs) can be engineered to express specific genes, either for their use in cell-based
therapies or to track them in vivo over long periods of time. To obtain long-term expression of these genes, a lentivirus- or
retrovirus-mediated cell transduction is often used. However, given that the efficiency with these viruses is typically low in
primary cells, additives such as polybrene are always used for efficient viral transduction. Unfortunately, as presented here,
exposure to polybrene alone at commonly used concentratons (1–8 mg/mL) negatively impacts hMSC proliferation in a
dose-dependent manner as measured by CyQUANT, EdU incorporation, and cell cycle analysis. This inhibition of
proliferation was observable in culture even 3 weeks after exposure. Culturing the cells in the presence of FGF-2, a potent
mitogen, did not abrogate this negative effect of polybrene. In fact, the normally sharp increase in hMSC proliferation that
occurs during the first days of exposure to FGF-2 was absent at 4 mg/mL or higher concentrations of polybrene. Similarly,
the effect of stimulating cell proliferation under simulated hypoxic conditions was also decreased when cells were exposed
to polybrene, though overall proliferation rates were higher. The negative influence of polybrene was, however, reduced
when the cells were exposed to polybrene for a shorter period of time (6 hr vs 24 hr). Thus, careful evaluation should be
done when using polybrene to aid in lentiviral transduction of human MSCs or other primary cells, especially when cell
number is critical.
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Introduction
Mesenchymal stem cells (MSCs) were originally isolated from
human bone marrow (BM) aspirates and characterized by their
adherence to plastic and their ability to differentiate into multiple
cell types, such as chondrocytes, adipocytes, and osteoblasts [1,2].
Since then, the therapeutic use of MSCs has been expanded
through genetic modification of the cell. For instance, MSCs have
been found to increase cardiac myocyte survival in an acute
myocardial infarction model when the cells were engineered to
overexpress SDF-1 [3]. In another example, Kumar et al. showed
that MSCs were able to increase their engraftment to BM,
normally a very rare event [4], when a4 integrin was transiently
upregulated [5]. MSCs can also be used to treat cancer by
exploiting the naturally high tumor tropism of MSCs with cells
genetically modified to secrete cancer-killing drugs and thus act as
drug delivery vehicles. For instance, the infusion of human MSCs
(hMSCs) transfected with an adenovirus to release IFN-b
significantly increased animal survival in a mouse glioma model
[6]. Additionally, the tumor tropism can be further enhanced by
modifying hMSCs to express on their cell surface a single-chain
antibody to the EGFRvIII found on glioblastoma multiforme
cancer cells [7].
In the examples presented above, short-term expression of the
engineered gene might be enough to generate a physiological
response, and hence methods such as adenoviral transfection
might be sufficient in those cases. However, long-term gene
expression by MSCs is desirable for situations where sustained
expression is required. For example, MSCs have been proposed as
treatment for genetic disorders such as Osteogenesis Imperfecta, in
which a mutation in the type I collagen gene causes severely
weakened bone structure and high rates of bone fractures. In one
potential gene-related therapy, the patient’s MSCs would be
harvested, the genetic mutation corrected ex vivo, and the
engineered cells delivered to the patient [8]. Another important
use of long-term gene expression is in cell tracking studies,
particularly those that require either long-term monitoring of
engraftment efficiency with a quantitative assessment (where stable
expression over time is needed) or in situations where the cell
population is expected to expand in vivo. In such cases, labeling of
hMSCs with GFP [9], LacZ [10], or luciferase [11] has been used.
One method to obtain successful long-term expression is to
transduce MSCs with a retrovirus or lentivirus. Unfortunately,
incubating a retrovirus or lentivirus alone with hMSCs results in
very low transduction efficiencies [9], and increasing the viral titers
does little to improve the efficiency. It is often required to have an
additive in solution, the most common being polybrene. Polybrene
(hexadimethrine bromide) is a cationic polymer discovered to
enhance retroviral transduction [12]. It is believed that it exerts its
effects by neutralizing the negative electrostatic repulsion between
the cell surface and the virus particles, allowing the latter to be
adsorbed easily onto the cell surface [13–15]. This adsorption does
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temperature-independent. Polybrene is considered non-toxic at
low concentrations, but has been found to negatively affect cell
proliferation in some cell types, such as keratinocytes, at
concentrations greater than 10 mg/mL [16]. In our attempts to
transduce hMSCs with lentivirus, we observed that hMSC
proliferation was also affected by polybrene. However, the impact
of polybrene on hMSCs has not been described previously.
We report here that polybrene alone can dramatically decrease
hMSC proliferation, especially at the commonly used concentra-
tions of 4 and 8 mg/mL. We found that after polybrene exposure
hMSCs did not regain their proliferative capabilities even after 3
weeks in culture and that FGF-2, a potent mitogen for hMSCs
[17], did not overcome the inhibitory effects of polybrene. These
inhibitory effects were reduced by both a decrease in the time of
exposure and in the dose of polybrene below 4 mg/mL. The
inhibitory effects were also reduced by culturing the cells under
simulated hypoxic conditions, which increased overall prolifera-
tion rates, although the negative effect of polybrene was still
present.
Results
Effect of polybrene on proliferation
When hMSCs were cultured in the presence of 8 mg/mL of
polybrene in 6-well plates, 100 mm dishes, or T175 flasks, their
proliferation rate was dramatically decreased as observed by phase
contrast microscopy (Fig. 1) and subsequent cell counts (data not
shown). There was no difference in the initial attachment of the
cells. This inhibition of proliferation was observed with multiple
donors and with two different lots of hMSC-screened serum.
To titrate the effect that different concentrations of polybrene
have on hMSC proliferation and to determine whether exposure
time has an impact, hMSCs were exposed to polybrene at
concentrations ranging from 0 mg/mL to 8 mg/mL for different
incubation times (Fig. 2A). Under standard culture conditions, the
number of cells increased over 5-fold after 21 days. In contrast,
with a polybrene treatment that is typically used for lentiviral
transduction (8 mg/mL for 24 hr), the number of hMSCs only
doubled within the same period of time (Fig. 2A). The difference
in cell numbers between these groups can be observed as early as 7
days. Decreasing the concentration of polybrene reduced its
negative effect on cell proliferation. However, even at 1 mg/mL of
polybrene, the cell numbers never achieved a level equivalent to
the control cells after 3 weeks of incubation. Decreasing the
exposure time from 24 to 6 hr also reduced but did not eliminate
the proliferative inhibition.
Overcoming polybrene inhibition with FGF-2
In an attempt to overcome polybrene inhibition, cells were
exposed to FGF-2, a known mitogenic agent. As expected, the
presence of FGF-2 significantly increased the proliferation rate
of the control cells (Fig. 2B). This effect was more dramatic
during the first week of stimulation when a steep increase in cell
number was followed by a plateau around the time of cell
confluence. However, at higher concentrations of polybrene (4
and 8 mg/ml), the mitogenic effect was completely blocked and
the proliferation rates were similar to those of polybrene treated
cells in the absence of FGF-2 (Fig. 2). Phenotypically, while the
hMSCs did not increase their proliferation, they did adopt a
more spindle-like morphology typically found with FGF-2
treated control cells.
Overcoming polybrene inhibition with hypoxia
To test whether hypoxic conditions can overcome the polybrene
inhibition of hMSC proliferation, cells were cultured in a larger
volume of medium to increase the medium height and thereby
simulate hypoxic conditions. Human MSC cell numbers increased
dramatically under these conditions (Fig. 3). Interestingly, the
hypoxic conditions delayed the effects of contact inhibition as the
control cells continued to proliferate rapidly up to day 14 (Fig. 3),
while there was a decrease in the proliferation rate under normal
oxygen conditions after day 7 (Fig. 2). By phase contrast
microscopy, a higher cell density was seen in cultures with
200 ml of medium compared to 50 ml of medium (Fig. 4). While
the proliferation was still inhibited by polybrene in a dose-
dependent way, hMSCs exposed to 8 mg/mL of polybrene in
200 ml of medium had a higher cell number per well at day 21
than untreated cells cultured in 50 ml of medium (23 k64 k vs.
11 k60.5 k). Overall the cell numbers at all polybrene concen-
trations were much closer to control under simulated hypoxic
conditions.
Figure 1. Phase contrast image of hMSCs exposed to polybrene. Phase contrast image of hMSCs either not exposed or exposed to 8 mg/mL
of polybrene for 24 hr and then cultured for another 7 days in 100 mm dishes. Black bar =750 mm.
doi:10.1371/journal.pone.0023891.g001
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The number of cells obtained at a single time point is
determined by the rate of cell proliferation and the rate of cell
death. Therefore, at each time point trypan blue was used to
measure dead cells to rule out cell death as a contributing factor in
the decreased cell number. No difference was ever noticed
between untreated and polybrene treated cultures with regard to
the number of trypan blue stained cells (data not shown).
However, interestingly, trypsinized cells exposed to polybrene
were visibly larger in size when viewed under the microscope (data
not shown).
To determine how polybrene affected the cell cycle, the cellular
DNA was analyzed with propidium iodide (PI) and EdU (5-
ethynyl-29-deoxyuridine). Cell cycle analysis with PI indicated a
decrease in the percentage of cells entering S phase with increasing
concentrations of polybrene (Fig. 5A-B). As expected, there were
higher numbers of cells in S phase in the presence of FGF-2, but
the same decrease in cells entering S phase was still observed for
cells treated with polybrene (Fig. 5A).
To measure the percentage of cells proliferating, hMSCs were
incubated with EdU for 24 hr before harvest. Like BrdU, EdU is a
thymidine analogue that will become incorporated into the DNA
Figure 2. Inhibition of hMSC proliferation after polybrene exposure. Plot of cell number over 21 days as measured by the CyQUANT assay.
Human MSCs were seeded at the same density in 96-well plates, exposed to different concentrations of polybrene for different lengths of time, and
cultured in 50 ml of medium per well without (A) or with FGF-2 (B). The untreated controls are the same for the different time points. The graphs are
all on the same scale. Values are mean 6 SD.
doi:10.1371/journal.pone.0023891.g002
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cytometry using the Click-iT EdU assay kit. As a function of
polybrene concentration, there was a steep decrease between
1 mg/mL and 4 mg/mL for both FGF-2 treated and untreated
cells (Fig. 5C).
Effect of polybrene concentration on transduction
efficiency
To measure if transduction can still be improved with low
concentrations of polybrene, hMSCs were incubated with
lentivirus containing a fused dual reporter gene that codes for
firefly luciferase and monomeric red fluorescent protein (mRFP).
The expression of mRFP, as measured by flow cytometry, showed
a dose-dependent increase with increasing polybrene concentra-
tion (Fig. 6A). Transgene expression in the target cells was also
closely correlated to the bioluminescence signal (Fig. 6B & C).
The proliferation of transduced hMSCs was inhibited similar to
hMSCs exposed to polybrene alone (data not shown).
Discussion
From the experiments described in this paper, we found that
culturing hMSCs in the presence of polybrene alone is sufficient to
inhibit their proliferation under standard culture conditions. The
CyQUANT assay showed that the number of cells in polybrene
treated wells was lower than that for untreated wells. However, the
Figure 3. Effect of hypoxic conditions on polybrene inhibition of hMSC proliferation. Plot of cell number over 21 days as measured by the
CyQUANT assay of hMSCs cultured in 200 ml of medium per well in the absence (A) or presence (B) of FGF-2. The untreated controls are the same for
the different time points. The graphs are all on the same scale. Values are mean 6 SD.
doi:10.1371/journal.pone.0023891.g003
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numbers can only indicate either that the cells are dying and
proliferating at a similar rate or that they are not proliferating. The
fact that cell cycle analysis with PI showed fewer cells in S phase
and that EdU incorporation over 24 hr was lower with increasing
polybrene concentration provide evidence that the cells were not
proliferating. Furthermore, there was no increase in trypan blue
stained cells in polybrene treated cultures, which indicates that
there was not an increase in cell death.
In an attempt to overcome the inhibition of proliferation by
polybrene, hMSCs were incubated with FGF-2, which has been
shown to be a potent mitogen for hMSCs [17]. Unlike cells not
exposed to polybrene, for which FGF-2 had a clear mitogenic
effect, there was no difference between FGF-2 treated or untreated
cells at higher concentrations of polybrene. However, polybrene
treated cells still adopted the spindle morphology typically found
with FGF-2 treated hMSCs, suggesting that FGF-2 still had an
effect on those cells.
An alternative method to increase hMSC proliferation is by
culturing the cells under hypoxic conditions. Recent reports have
indicated that hMSCs can increase their proliferation while
maintaining their differentiation potential under low oxygen
conditions [18–20]. We mimicked these conditions by increasing
the height of the medium. According to Fick’s first law of diffusion,
the rate of oxygen delivery per unit area to the cell is inversely
proportional to the height of the medium to the first order [21].
This equation has been confirmed experimentally [22,23]. Our
initial culture of hMSCs in 50 ml of medium per well of a 96-well
plate had a medium height of approximately 156 mm, which is
close to our standard medium height of approximately 127 mmi n
a 100 mm dish. We were able to decrease the amount of available
oxygen by 25% by increasing the medium height four-fold with
the use of 200 ml per well. After 3 weeks in culture, we obtained 4
times more cells with the increased medium height compared to
the 50 ml medium height. We also report for the first time that
FGF-2 and hypoxia have a synergistic effect in increasing hMSC
proliferation, suggesting that the two act under different
mechanisms. After 3 weeks, there were 26% more cells in the
FGF-2 treated group. Also, it appears that the hypoxic condition
was able to partially overcome contact inhibition. Based on the
data in Fig. 2, confluence was reached at approximately 1.1610
4
cells per well. In contrast, growth plateaued at approximately
5610
4 cells per well under hypoxic conditions. This could be due
to the fact that the cells were smaller as can be observed in Fig. 4.
In addition, culturing under low oxygen did not completely
antagonize the effect of polybrene as the cell yields were still lower
compared to control. However, the effect of polybrene was greatly
reduced at lower concentrations, and at high concentration (8 mg/
mL) hypoxic conditions still resulted in twice as many cells as
unexposed hMSCs cultured under non-hypoxic conditions.
Collectively, these data support the beneficial effect of hypoxic
culture conditions for hMSCs, even when polybrene is used as an
adjuvant of cell transduction.
We also suspected that shortening the polybrene exposure time
might mitigate the adverse effect of polybrene on hMSC
proliferation. This did have a small effect under normal oxygen
conditions, but the benefit was more noticeable with cells cultured
under low oxygen. With a 6 hr exposure to 1 mg/mL of polybrene,
the growth curve was almost identical to unexposed cells in either
the presence or absence of FGF-2.
These studies emphasize the need to re-examine the appropriate
conditions for viral transduction of hMSCs when polybrene is
used. Using a lentivirus carrying a fused dual reporter gene, we
found that there was a positive correlation between transduction
efficiency and increasing concentrations of polybrene. Although
1 mg/mL of polybrene had the lowest percentage of transduced
cells, there was still an over three-fold increase in transduction
efficiency compared to transduction in the absence of polybrene.
Furthermore, proliferation was inhibited by only 30% under
standard culture conditions and 9% under hypoxic conditions.
The lower transduction efficiency might not be problematic if the
cells can proliferate to a greater degree so that it would be possible
to obtain a larger number of transduced cells in the end. Hence,
utilizing this lower dose of polybrene might be an acceptable
compromise, especially when paired with low oxygen culture.
Polybrene is a widely used supplement in retroviral and
lentiviral transduction. Unfortunately, the adverse effect of
polybrene on the proliferation of hMSCs presents a technical
problem. With a low proliferation rate, it becomes difficult to
attain the large number of cells required for cellular therapies.
Figure 4. Phase contrast images of hMSCs cultured in 50 mlo r
200 ml of medium per well. Phase contrast images of hMSCs from
Fig. 2 and 3 that were either untreated or treated with to 8 mg/mL of
polybrene for 24 hr. Cells were cultured for 14 days in either normal
culture conditions (A) or under simulated hypoxic conditions (B). The
medium was removed prior to image capture. All images are at the
same magnification. The insert shows an increased magnification of the
cells. White bar =500 mm (100 mm in insert).
doi:10.1371/journal.pone.0023891.g004
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23891Figure 5. Cell cycle analysis with propidium iodide (PI) and EdU incorporation. Human MSCs were incubated with polybrene for 24 hr and
then cultured for another 4 days in 100 mm dishes with 7 mL of medium per dish. (A) Cell cycle analysis with PI of hMSCs at different polybrene
concentrations in the absence or presence of FGF-2. (B) Sample cell cycle histograms of hMSCs incubated in the absence of FGF-2 at 0 and 8 mg/mL of
polybrene. (C) Proliferation measurement by EdU incorporation for hMSCs treated and untreated with FGF-2 at different polybrene concentrations
(*p,0.001 vs. 0 mg/mL and 1 mg/mL, Tukey t-test). Values are mean 6 SD.
doi:10.1371/journal.pone.0023891.g005
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initially require large quantities of virus and a large number of
hMSCs, making pre-clinical experiments and potential therapy
costly and difficult. Furthermore, viral transduction with poly-
brene could interfere with the engraftment and proliferation of
transduced hMSCs in vivo. The fact that polybrene can affect
hMSC proliferation and cell morphology also begs the question as
to whether polybrene has other potential side effects on the cells.
Thus, the use of polybrene with hMSCs must be done with
caution.
Materials and Methods
Human MSC isolation and culture
Isolation of hMSCs was performed as described before [24,25].
Briefly, bone marrow aspirates were obtained from the posterior
superior iliac crest of healthy adult donors who gave written
consent (IRB approved protocol from University Hospitals,
Cleveland, OH). The cells were washed once with Dulbecco’s
Modified Eagle’s Medium (DMEM-LG, Sigma Chemical) supple-
mented with 10% fetal bovine serum (FBS) that had been screened
for hMSC culture [26]. The cells were centrifuged and then
resuspended in 5 mL of medium and placed on top of 35 mL of
63% (v/v) Percoll gradient. After centrifuging at 460 g for 15
minutes, the top 25% of the gradient containing the nucleated cells
was transferred to a new tube and washed again. The nucleated
cells were then seeded at a density of 1.8610
5 per cm
2 and
cultured for 2 weeks before initial passage in DMEM-LG
supplemented with 10% FBS. Medium was changed every 3-4
days for each passage. Cells were passaged every week with
trypsin-EDTA (0.25% trypsin, 4 mM EDTA, Gibco) and seeded
at 3–4.5610
3 per cm
2 in 100 mm tissue culture dishes and
cultured in 7 mL of medium. Passages 1 to 3 were used for the
experiments described herein.
Proliferation analysis
Trypsinized cells were washed and resuspended in medium
at 2610
4 cells/mL with or without rhFGF-2 (final concen-
tration =10 ng/mL, PeproTech) and with or without polybrene
(Sigma Chemical) at a final polybrene concentration of 1, 4, or
Figure 6. Lentiviral transduction of hMSCs with polybrene. Human MSCs were cultured with lentivirus containing a dual reporter gene that
encodes a fusion protein of luciferase and mRFP. (A) Positive correlation of transduction efficiency with polybrene concentration as determined by
mRFP flow analysis. (Spearman corr. coeff. =0.95, p,0.001) Values are mean 6 SD. (B) Image of the bioluminescence signal from the transduced
cells. (C) Chart of the number of photons detected in each well as a function of polybrene concentration. (Spearman corr. coeff. =0.97, p,0.001)
Values are mean 6 SD.
doi:10.1371/journal.pone.0023891.g006
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1610
3 cells in 50 ml per well in triplicate and cultured at 37uC, 5%
CO2. After 6, 9, or 24 hr, the medium was changed and
subsequent medium changes occurred every 3–4 days with 50 ml
of +/– FGF-2 medium (10 ng/mL). Plates were harvested on day
4, 7, 14, and 21 by removing the medium and placing the plates in
the 280uC freezer until the day of analysis. The CyQUANT assay
(Molecular Probes) was then performed on the wells following the
manufacturer’s instructions.
For hypoxic studies, the cells were resuspended at 5610
3 cells/
mL and seeded in 96-well plates at 1610
3 cells in 200 ml per well
in triplicate. The cells were cultured in 200 ml of medium per well
for the duration of the experiment. The rest of the experiment was
performed as described above for cells cultured in 50 mlo f
medium.
Cell cycle analysis
Propidium iodide (PI). Human MSCs were seeded with
different concentrations of polybrene with or without FGF-2
(10 ng/mL) in 100 mm dishes. After 24 hr, the medium was
changed with 7 mL of fresh medium, and the cultures were
incubated for another 4 days. The cells were then trypsinized, and
fixed in 70% ethanol at 220uC for 10 min. The cells were washed
once with PBS, resuspended in RNase (0.2 mg/mL), and
incubated at 37uC for 10 minutes. An equal volume of PI was
added to obtain a final PI concentration of 50 mg/mL. The cells
were then analyzed on an EPICS XL flow cytometer.
Click-iT EdU assay. Cells were seeded at 1610
5 per well in
a 6-well plate in different concentrations of polybrene with or
without FGF-2. After 24 hr, the medium was replaced with
1.5 mL of fresh medium and the cultures were maintained for
another 4 days. EdU was added to the medium 24 hr before
harvest to obtain a final EdU concentration of 10 mM. The cells
were then trypsinized, and fixed in 4% formaldehyde. EdU
incorporation was determined with the Click-iT EdU Alexa Fluor
647 flow cytometry assay kit (Molecular Probes) according to the
manufacturer’s instructions.
Transduction with lentivirus
The reporter gene used is a modification of the triple fusion
reporter vector described previously [27] (gift from Dr. Zhen-
ghong Lee, Case Western Reserve University) that contains firefly
luciferase (fluc), monomeric red fluorescent protein (mrfp), and
herpes simplex thymidine kinase (ttk) domains in which the ttk
domain was removed with BamHI. The gene is driven by the
modified myeloproliferative sarcoma virus promoter (MND
promoter). The second generation replication-incompetent lenti-
virus was generated using a three-plasmid system in 293T cells
with the reporter plasmid, pCMVDR8.91 (packaging vector), and
pMD.G (vesicular stomatitis virus protein G pseudotyping vector).
Viral titers were determined with 293T cells.
To transduce the hMSCs, 1610
5 cells per well were seeded in
triplicate in 6-well plates with the lentivirus at a multiplicity of
infection (MOI) of 5 and with a final polybrene concentration of 0,
1, 4, or 8 mg/mL. After 24 hr, the medium was replaced, and the
cells were cultured for another 6 days with one additional medium
change. The cells were trypsinized and analyzed on the iCyt
Reflection flow cytometer for mRFP (ex: 561 nm, em: 615/30
Band Pass Filter) to determine the percentage of the cells that were
transduced. The cells were also seeded onto black 96-well plates in
triplicate at 5610
3 cells per 150 ml of medium and 25 mlo f
luciferin (Luciferase Assay System, Cat# E1500, Promega) per
well. The plate was imaged for 3 min with a field of view of 13 cm
using the Xenogen IVIS Imaging 200 Series system (Caliper Life
Sciences, Hopkinton, MA). Grids were drawn around each well
and the number of photons was calculated using the Living Image
software v2.5 (Caliper Life Sciences, Hopkinton, MA).
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